Literature DB >> 28382367

von Willebrand factor deficiency leads to impaired blood flow recovery after ischaemia in mice.

Margreet R de Vries, Erna A B Peters, Paul H A Quax, A Yaël Nossent1.   

Abstract

Neovascularisation, i. e. arteriogenesis and angiogenesis, is an inflammatory process. Therefore attraction and extravasation of leukocytes is essential for effective blood flow recovery after ischaemia. Previous studies have shown that von Willebrand factor (VWF) is a negative regulator of angiogenesis. However, it has also been shown that VWF facilitates leukocyte attraction and extravasation. We aimed to investigate the role of VWF in arteriogenesis and angiogenesis during post-ischaemic neovascularisation. Wild-type (WT) and VWF deficient (VWF-/-) C57BL/6 mice were subjected to hindlimb ischaemia via double ligation of the left femoral artery, and blood flow recovery was followed over time, using Laser Doppler Perfusion Imaging. Blood flow recovery was impaired in VWF-/- mice. After 10 days, VWF-/- mice showed a 43 ± 5 % recovery versus 68 ± 5 % in WT. Immunohistochemistry revealed that both arteriogenesis in the adductor muscles and angiogenesis in the gastrocnemius muscles were reduced in VWF-/- mice. Furthermore, leukocyte infiltration in the affected adductor muscles was reduced in VWF-/- mice. Residual paw perfusion directly after artery ligation was also reduced in VWF-/- mice, indicating a decrease in pre-existing collateral arteriole density. When we quantified collateral arterioles, we observed a 31 % decrease in the average number of collateral arterioles in the pia mater compared to WT mice (57 ± 3 in WT vs 40 ± 4 pial collaterals in VWF-/-). We conclude that VWF facilitates blood flow recovery in mice. VWF deficiency hampers both arteriogenesis and angiogenesis in a hindlimb ischaemia model. This is associated with impaired leukocytes recruitment and decreased pre-existing collateral density in the absence of VWF.

Entities:  

Keywords:  angiogenesis; arteriogenesis; ischaemia; neovascularisation; von Willebrand factor

Mesh:

Substances:

Year:  2017        PMID: 28382367     DOI: 10.1160/TH16-12-0957

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing.

Authors:  Jun Ishihara; Ako Ishihara; Richard D Starke; Claire R Peghaire; Koval E Smith; Thomas A J McKinnon; Yoji Tabata; Koichi Sasaki; Michael J V White; Kazuto Fukunaga; Mike A Laffan; Matthias P Lutolf; Anna M Randi; Jeffrey A Hubbell
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

2.  Von Willebrand factor exerts hepatoprotective effects in acute but not chronic cholestatic liver injury in mice.

Authors:  Lauren G Poole; Anna-Katherine Fournier; Holly M Cline-Fedewa; Anna K Kopec; James P Luyendyk; Dafna J Groeneveld
Journal:  Toxicology       Date:  2021-10-04       Impact factor: 4.571

Review 3.  von Willebrand factor regulation of blood vessel formation.

Authors:  Anna M Randi; Koval E Smith; Giancarlo Castaman
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

Review 4.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

5.  IRF3 and IRF7 mediate neovascularization via inflammatory cytokines.

Authors:  Karin H Simons; Margreet R de Vries; Rob C M de Jong; Hendrika A B Peters; J Wouter Jukema; Paul H A Quax
Journal:  J Cell Mol Med       Date:  2019-04-01       Impact factor: 5.310

6.  Lung adenocarcinoma-derived vWF promotes tumor metastasis by regulating PHKG1-mediated glycogen metabolism.

Authors:  Jiayi Gu; Yingxue Qi; Yuxin Lu; Qianying Tao; Die Yu; Chunchun Jiang; Jianwen Liu; Xin Liang
Journal:  Cancer Sci       Date:  2022-02-20       Impact factor: 6.716

7.  von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.

Authors:  Suzanne L Laboyrie; Margreet R de Vries; Alwin de Jong; Hetty C de Boer; Reshma A Lalai; Laisel Martinez; Roberto I Vazquez-Padron; Joris I Rotmans
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

Review 8.  The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.

Authors:  Chanukya K Colonne; Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Healthcare (Basel)       Date:  2022-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.